JPS57197295A - Manufacture of daunorubicin-protein composite body - Google Patents
Manufacture of daunorubicin-protein composite bodyInfo
- Publication number
- JPS57197295A JPS57197295A JP57074640A JP7464082A JPS57197295A JP S57197295 A JPS57197295 A JP S57197295A JP 57074640 A JP57074640 A JP 57074640A JP 7464082 A JP7464082 A JP 7464082A JP S57197295 A JPS57197295 A JP S57197295A
- Authority
- JP
- Japan
- Prior art keywords
- daunorubicin
- manufacture
- composite body
- protein composite
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
- A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8114167 | 1981-05-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS57197295A true JPS57197295A (en) | 1982-12-03 |
Family
ID=10521675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57074640A Pending JPS57197295A (en) | 1981-05-08 | 1982-05-06 | Manufacture of daunorubicin-protein composite body |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPS57197295A (en) |
BE (1) | BE893109A (en) |
DE (1) | DE3205847A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05239963A (en) * | 1991-08-09 | 1993-09-17 | Fujitsu Ten Ltd | Electronic lock device for car door |
JPH05239961A (en) * | 1991-08-09 | 1993-09-17 | Fujitsu Ten Ltd | Electronic lock device for car door |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51126281A (en) * | 1975-02-04 | 1976-11-04 | Searle & Co | Cytootoxic substance |
JPS51144723A (en) * | 1975-05-27 | 1976-12-13 | Yeda Res & Dev | Antiitumor agent |
-
1982
- 1982-02-18 DE DE19823205847 patent/DE3205847A1/en not_active Withdrawn
- 1982-05-06 JP JP57074640A patent/JPS57197295A/en active Pending
- 1982-05-07 BE BE0/208030A patent/BE893109A/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51126281A (en) * | 1975-02-04 | 1976-11-04 | Searle & Co | Cytootoxic substance |
JPS51144723A (en) * | 1975-05-27 | 1976-12-13 | Yeda Res & Dev | Antiitumor agent |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05239963A (en) * | 1991-08-09 | 1993-09-17 | Fujitsu Ten Ltd | Electronic lock device for car door |
JPH05239961A (en) * | 1991-08-09 | 1993-09-17 | Fujitsu Ten Ltd | Electronic lock device for car door |
Also Published As
Publication number | Publication date |
---|---|
DE3205847A1 (en) | 1982-12-16 |
BE893109A (en) | 1982-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3260285D1 (en) | Composite body | |
JPS57182301A (en) | Composite body of sugar-containing compound and cycloamlose and manufacture | |
JPS5738137A (en) | Manufacture of composite member | |
JPS57150628A (en) | Manufacture of alpha-alkylacrolein | |
JPS57193374A (en) | Manufacture of jet-nozzle-duct | |
JPS57100429A (en) | Manufacture of structural body | |
JPS57149605A (en) | Assembled body of brake | |
JPS57154140A (en) | Manufacture of hydroxyarylophenone | |
JPS57208328A (en) | Assembled body of brake | |
JPS57203037A (en) | Manufacture of p-nitrophenetol | |
JPS57212145A (en) | Manufacture of cyclohexyamine | |
JPS57185286A (en) | Manufacture of isosorbit-5-nitrate | |
GB2112689B (en) | Manufacture of composite tube | |
JPS57140389A (en) | Manufacture of composite fertilizer | |
JPS57149245A (en) | Manufacture of polychlorobenzoylchloride | |
JPS57159759A (en) | Manufacture of 4-haloazetidine-2-ones | |
JPS57138935A (en) | Manufacture of composite membrane | |
JPS5542234A (en) | Manufacture of gypsummresin composite body | |
JPS57182435A (en) | Manufacture of laminate | |
JPS57203075A (en) | Manufacture of halogen-2-mercaptobenzoxazole | |
JPS57135761A (en) | Calcium silicate-resin composite body and manufacture | |
JPS57195656A (en) | Manufacture of composite shape | |
JPS57209294A (en) | Manufacture of silylisocyanate | |
JPS57197295A (en) | Manufacture of daunorubicin-protein composite body | |
JPS57156381A (en) | Manufacture of ceramic-metal composite body |